赤痢菌(シゲラ)用ワクチンの世界市場機会分析...市場調査レポートについてご紹介

【英文タイトル】MarketVIEW: Shigella vaccines - Vaccine opportunity assessment

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

※レポート紹介PDF⇒http://www.vaczine-analytics.com/VAMV067_TOC_190120.pdf

****This product is composed of one forecast model and a summary presentation

Title page
Contents
Author’s note
Shigella: country risk definitions
Executive summary
Commercial model: key outputs
Shigella vaccines: global forecast revenue ($m) to 2035
Shigella vaccines: global forecast volume (000s doses) to 2035
Shigella vaccines: volume (000s doses) by country risk to 2035
Shigella vaccines: breakdown per endemic countries to 2035
Shigella vaccines: breakdown by Traveller origin (overall and High-risk) to 2035
Shigella vaccines: breakdown by Traveller origin (Medium-risk and Low-risk)
Shigella vaccines: country market share in 2030 (endemic and travellers)
Shigella spp. Disease background and epidemiology
Shigella spp. – The pathogens
Transmission of Shigella
Pathophysiology of shigellosis
Shigella toxins
Clinical presentation of shigellosis
Complications of shigellosis
Shigella is an important cause of diarrhoea globally
Incidence of shigellosis by geographic region, 1984-2005
Global distribution of Shigella species
Epidemiology of Shigella spp.
Seroepidemiology of S. flexneri
Morbidity and mortality associated with shigellosis
Risk factors for shigellosis – developing regions
Risk factors for shigellosis – industrialised regions
Risk factors for shigellosis in travellers
Economic burden of shigellosis
Treatment of shigellosis: Current approaches
Antimicrobial therapy for shigellosis
Antibiotic resistance in Shigella
Vaccination against Shigella spp. Rationale and approaches
Rationale for vaccination against Shigella
Approaches to a Shigella vaccine
Choice of serotypes for a vaccine
History of Shigella vaccine development
Shigella spp. vaccines in development: overview of current R&D
History of Shigella vaccine development
Vaccines in development (1) – live attenuated vaccines
Vaccines in development (2) – inactivated and other vaccines
Clinical trial data – live attenuated vaccines
Clinical trial data – subunit and conjugate vaccines
Potential lead candidates for licensure
Shigella spp. vaccines: target product profiles
Shigella spp. vaccines: modelling the potential market
Modelling assumptions: endemic countries
Modelling assumptions: countries of traveler origin
Case data: hepatitis A vaccine uptake rate in international travellers
Bibliography
About VacZine Analytics
Disclaimer


【レポート販売概要】

■ タイトル:赤痢菌(シゲラ)用ワクチンの世界市場機会分析
■ 英文:MarketVIEW: Shigella vaccines - Vaccine opportunity assessment
■ 発行日:2016年1月
■ 調査会社:VacZine Analytics
■ 商品コード:VACZ60302
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。